MSK's AI-Designed Anti-Cancer Proteins Fully Clear Tumors in Mice

MSK's Caleb Lareau lab spent three years using generative AI to design cancer-binding proteins, publishing in Nature Biomedical Engineering; the AI-engineered CARs fully cleared tumors in vivo, outperforming FDA-approved binders, with the team planning further preclinical work.

2026-09-10 ~ 2026-09-10 · 3 related posts

• MSK lab uses generative AI to design cancer binders that beat FDA-approved CAR T proteins in mice — anshulkundaje · 2026-09-10
• MSK researcher: AI-designed proteins to push tumor-control limits in preclinical models — anshulkundaje · 2026-09-10
• AI-engineered CAR binders completely cleared tumors in vivo where FDA-approved binders failed — anshulkundaje · 2026-09-10